If you’re tired of dealing with myopia and constant contact or eyeglass contact, EVO Visian ICL™ (STAAR® Surgical Phakic ICL for Myopia and Astigmatism) may be just what you’ve been waiting for, and after more than Twenty years outside the US, it’s finally available in Utah at Hoopes Vision.
On March 28, 2022, the STAAR Surgical Company, a leading manufacturer of implantable lenses, announced in a press release that the U.S. Food and Drug Administration (FDA) approved EVO/EVO+ Visian® Implantable Collamer® Lens (EVO) as a safe Myopia with and without astigmatism and effective treatments in the US
“More than 1 million EVO lenses have been implanted by physicians outside the U.S., and 99.4% of EVO patients in a survey said they would undergo surgery again,” said Caren Mason, president and CEO of STAAR Surgical.
“Sales of EVO lenses outside the U.S. increased 51% in 2021, more than doubling since 2018, reflecting the increasing choice of patients and our surgeon partners for EVO as a premium option for refractive correction and major solutions.”
Contact Lens Removal Tool
This highly effective same-day vision correction procedure can be completed in approximately 20-30 minutes.Not only is the procedure quick and painless, the EVO ICL has the advantage of a quick recovery time, no need for contact lenses and glasses, and improved distance and night vision almost overnight – for many people frustrated by contact lenses or glasses, A dream come true.
Myopia, also known as “nearsightedness,” is one of the most common vision conditions worldwide, where an individual can see close objects clearly, but distant objects appear blurry.According to the National Eye Institute (NEI), “Multiple studies suggest that the prevalence of myopia is increasing in the United States and worldwide, and researchers expect this trend to continue for decades to come.”
Myopia occurs when a person’s eyes grow too long from front to back, causing light to refract or “bend” incorrectly.About 41.6 percent of Americans are nearsighted, “up from 25 percent in 1971,” the NEI report said.
STAAR Surgical estimates that 100 million U.S. adults between the ages of 21 and 45 may be potential candidates for EVO, a well-tolerated lens that corrects a person’s distance vision, allowing them to see more distant objects.
EVO Visian lenses are also known as “Implantable Collamer® Lenses”.Lenses are made of STAAR Surgical’s proprietary Collamer material.It contains a small amount of purified collagen and the rest is made of a similar material found in soft contact lenses.Collamer is soft, stable, flexible and biocompatible.Collamer has a history of successful intraocular use worldwide and has proven to be a comfortable and effective ophthalmic lens material.
Before EVO Visian ICL surgery, your doctor will perform a series of tests to measure the unique characteristics of your eye.Immediately before surgery, your doctor will use eye drops to dilate your pupils and numb your eyes.Next, the EVO ICL lens will be folded and inserted into a small opening in the limbus of the cornea.
Contact Lens Removal Tool
After inserting the lens, the doctor will make any necessary adjustments to ensure the correct positioning of the lens.The lens will be placed firmly behind the iris (the colored part of the eye) and in front of the natural lens.Once the lens is installed, you and others can’t see it, and the soft, flexible lens fits comfortably with your natural eye.
For more than 20 years, STAAR’s implantable Collamer lenses have been helping patients achieve better vision, freeing them from glasses and contact lenses, and finally, EVO ICL received FDA approval for U.S. patients
“We are pleased to offer EVO to U.S. surgeons and patients seeking a proven option for high-quality eyeglasses, contact lenses, or laser vision correction,” said Scott D. Barnes, MD, Chief Medical Officer of STAAR Surgical. “Today’s announcement is particularly important, Because the prevalence of myopia is rapidly increasing, COVID precautions pose additional challenges for those who wear glasses and/or contact lenses.
“EVO adds an important tool to ophthalmologists looking to help improve a patient’s quality of life. Unlike LASIK, EVO lenses are added to a patient’s eye through a relatively quick surgical procedure, without the need to remove corneal tissue. In addition, if desired, physicians can EVO lenses removed. The results of our recent clinical trial in the U.S. are consistent with the more than one million EVO lenses that have been implanted worldwide.”
EVO is an FDA-approved vision correction option for myopic patients with or without astigmatism who want to eliminate the need for glasses or contact lenses.While EVO is a long-term solution to relieve patients from the daily inconvenience of contact and wearing glasses, it is likely that EVO is not suitable for those who have undergone LASIK, as the procedure has not been established as a safe procedure for patients with a history of eye disease .
Are you ready to live a full life?To find out if the EVO ICL program is right for you, please contact Hoopes Vision to schedule your VIP consultation.At Hoopes Vision, patients enjoy an excellent safety record and proven results, while appreciating how they do everything they can to make optimal vision correction affordable and within reach for patients with different budgets.
Post time: May-21-2022
